Rajani Associates advises Beaufond Industries on Resolution Plan for Kobo Biotech
Rajani Associates advised Beaufond Industries Limited, the Successful Resolution Applicant, in relation to the resolution plan of Kobo Biotech Limited. The resolution plan, valued at approximately ₹70 crore, was submitted to the Committee of Creditors on March 4, 2026, approved by the Committee of Creditors on March 17, 2026, and subsequently approved by the National Company Law Tribunal on May 11, 2026. As part of the resolution process, Rajani Associates advised on the resolution plan and the composite scheme of amalgamation and arrangement. The approved resolution plan provides for the merger of Beaufond Industries with Kobo…
SectorPharma & Healthcare
Value₹70 cr
Sources
Open in the live tracker →Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026